Cargando…
PKD3 promotes metastasis and growth of oral squamous cell carcinoma through positive feedback regulation with PD-L1 and activation of ERK-STAT1/3-EMT signalling
Oral squamous cell carcinoma (OSCC) has a high incidence of metastasis. Tumour immunotherapy targeting PD-L1 or PD-1 has been revolutionary; however, only a few patients with OSCC respond to this treatment. Therefore, it is essential to gain insights into the molecular mechanisms underlying the grow...
Autores principales: | Cui, Bomiao, Chen, Jiao, Luo, Min, Liu, Yiying, Chen, Hongli, Lü, Die, Wang, Liwei, Kang, Yingzhu, Feng, Yun, Huang, Libin, Zhang, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946959/ https://www.ncbi.nlm.nih.gov/pubmed/33692335 http://dx.doi.org/10.1038/s41368-021-00112-w |
Ejemplares similares
-
Protein kinase D3 regulates the expression of the immunosuppressive protein, PD-L1, through STAT1/STAT3 signaling
por: Cui, Bomiao, et al.
Publicado: (2020) -
Small-Molecule Inhibitor Targeting Protein Kinase D: A Potential Therapeutic Strategy
por: Lv, Die, et al.
Publicado: (2021) -
Characterisation of transcription factor profiles in polycystic kidney disease (PKD): identification and validation of STAT3 and RUNX1 in the injury/repair response and PKD progression
por: Formica, Chiara, et al.
Publicado: (2019) -
ERK is a negative feedback regulator for IFN-γ/STAT1 signaling by promoting STAT1 ubiquitination
por: Zhang, Ying, et al.
Publicado: (2018) -
Structural basis for Ca(2+) activation of the heteromeric PKD1L3/PKD2L1 channel
por: Su, Qiang, et al.
Publicado: (2021)